Researchers analyzed 22 randomized trials with 100,000 subjects. The current 23-valent vaccine was used in eight trials, and previous lower-valent vaccines were used in the others.

Findings based on efforts in Sera Town, Japan showed the pneumococcal vaccination support program reversed the previously ...

Objectives We assessed the impact of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following administration of the 23-valent pneumococcal ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

Direct & Indirect Effects in the USA, Canada & Australia In the USA, routine infant pneumococcal vaccination was implemented in the second half of the year 2000 for all children 2–23 months of ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Objective To evaluate tofacitinib's effect upon pneumococcal and influenza vaccine immunogenicity. Methods We conducted two studies in patients with rheumatoid arthritis using the 23-valent ...

This study investigated pneumococcal antibody responses, including persistence of antibodies, after immunisation of healthy infants with a 3+0 schedule. Methods We measured pneumococcal antibody ...

Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening ...

However, if these kids received the 13-valent PCV (PCV13; Prevnar 13) or PCV15, the recommendation is for one dose of PCV20 or the 23-valent polysaccharide vaccine (PPSV23; Pneumovax 23).

"In retrospect, it was a great decision." Omada goes public at $23 per share. But Omada does have the pandemic to thank for its growth, as it put a spotlight on digital health services.